AZD9496

News alerts, weekly reports and conference planners

Company:

AstraZeneca

Drug class:

Selective estrogen receptor degrader

Related drugs:

ER D538G	Breast Cancer	ER D538G	Breast Cancer	AZD9496 Sensitive: D – Preclinical AZD9496 Sensitive : D	AZD9496 Sensitive: D – Preclinical AZD9496 Sensitive : D
MPZL3 overexpression	Breast Cancer	MPZL3 overexpression	Breast Cancer	AZD9496 Resistant: D – Preclinical AZD9496 Resistant : D	AZD9496 Resistant: D – Preclinical AZD9496 Resistant : D

Associations
(2)